Low molecular weight hyaluronic acid increases the self-defense of skin epithelium by induction of β-defensin 2 via TLR2 and TLR4

Journal of Immunology

Volumn 181, Issue 3, 2008, Pages 2103-2110

  Gariboldi, Silvia ^a   Palazzo, Marco ^a   Zanobbio, Laura ^a   Selleri, Silvia ^a   Sommariva, Michele ^a   Sfondrini, Lucia ^a   Cavicchini, Stefano ^b   Balsari, Andrea ^a,c   Rumio, Cristiano ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 2; HYALURONIC ACID DERIVATIVE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LOW MOLECULAR WEIGHT HYALURONIC ACID; PROTEIN C FOS; PROTEIN KINASE C; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA DEFENSIN; CELL EXTRACT; CYTOKINE; DEFB2 PROTEIN, MOUSE; DEFB4 PROTEIN, HUMAN; HYALURONIC ACID; LIPOPOLYSACCHARIDE; PEPTIDOGLYCAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; CELL ACTIVATION; CELL COMPARTMENTALIZATION; CELL PROTECTION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; EX VIVO STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SELF DEFENSE; SIGNAL TRANSDUCTION; SKIN CULTURE; SKIN EPITHELIUM; SKIN INFECTION; SKIN PROTECTION; ANIMAL; BIOPSY; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; DRUG EFFECT; DRUG POTENTIATION; EPITHELIUM; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR WEIGHT; MOUSE MUTANT; SECRETION; SKIN;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-DEFENSINS; BIOPSY; CELL EXTRACTS; CELL LINE; CYTOKINES; EPITHELIUM; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; HUMANS; HYALURONIC ACID; KERATINOCYTES; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR WEIGHT; PEPTIDOGLYCAN; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-FOS; SIGNAL TRANSDUCTION; SKIN; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 49649127951     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.3.2103     Document Type: Article

References (41)

1. Kanda, N., and S. Watanabe. 2007. Histamine enhances the production of human β-defensin-2 in human keratinocytes. Am. J. Physiol. 293: C1916-C1923.
2. Braff, M. H., and R. L. Gallo. 2006. Antimicrobial peptides: an essential component of the skin defensive barrier. Curr. Top. Microbiol. Immnunol. 306: 91-110.
3. Donnarumma, G., I. Paoletti, E. Buommino, M. Orlando, M. A. Tufano, and A. Baroni. 2004. Malassezia furfur induces the expression of β-defensin-2 in human keratinocytes in a protein kinase C-dependent manner. Arch. Dermatol. Res. 295: 474-481.
4. Jiang, D., J. Liang, J. Fan, S. Yu, S. Chen, Y. Luo, G. D. Prestwich, M. M. Mascarenhas, H. G. Garg, D. A. Quinn, et al. 2005. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med. 11: 1173-1179.
5. Termeer, C., F. Benedix, J. Sleeman, C. Fieber, U. Voith, T. Ahrens, K. Miyake, M. Freudenberg, C. Galanos, and J. C. Simon. 2002. Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4. J. Exp. Med. 195: 99-111.
6. Scheibner, K. A., M. A. Lutz, S. Boodoo, M. J. Fenton, J. D. Powell, and M. R. Horton. 2006. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J. Immunol. 177: 1272-1281.
7. Selleri, S., F. Arnaboldi, M. Palazzo, S. Gariboldi, L. Zanobbio, E. Opizzi, Y. F. Shirai, A. Balsari, and C. Rumio. 2007. Toll-like receptor agonists regulate β-defensin 2 release in hair follicle. Br. J. Dermatol. 156: 1172-1177.
8. Schroder, J. M., and J. Harder. 1999. Human β-defensin 2. Int. J. Biochem. Cell Biol. 31: 645-651.
9. Chronnell, C. M., L. R. Ghali, R. S. Ali, A. G. Quinn, D. B. Holland, J. J. Bull, W. J. Cunliffe, I. A. McKay, M. P. Philpott, and S. Muller-Rover. 2001. Human β defensin-1 and -2 expression in human pilosebaceous units: upregulation in acne vulgaris lesions. J. Invest. Dermatol. 117: 1120-1125.
10. Sikkink, C. J., M. M. Reijnen, P. Falk, H. van Goor, and L. Holmdahl. 2005. Influence of monocyte-like cells on the fibrinolytic activity of peritoneal mesothelial cells and the effect of sodium hyaluronate. Fertil. Steril. 84 (Suppl. 2): 1072-1077.
11. Zou, L., X. Zou, L. Chen, H. Li, T. Mygind, M. Kassem, and C. Bünger. 2007. Effect of hyaluronan on osteogenic differentiation of porcine bone marrow stromal cells in vitro. J. Orthop. Res. 26: 713-720.
12. Santangelo, K. S., A. L. Johnson, A. S. Ruppert, and A. L. Bertone. Effects of hyaluronan treatment on lipopolysaccharide-challenged fibroblast-like synovial cells. 2007. Arthritis Res. Ther. 9: R1.
13. Rosines, E., H. J. Schmidt, and S. K. Nigam. 2007. The effect of hyaluronic acid size and concentration on branching morphogenesis and tubule differentiation in developing kidney culture systems: potential applications to engineering of renal tissues. Biomaterials 28: 4806-4817.
14. Trabucchi, E., S. Pallotta, M. Morini, F. Corsi, R. Franceschini, A. Casiraghi, A. Pravettoni, D. Foschi, and P. Minghetti. 2002. Low molecular weight hyaluronic acid prevents oxygen free radical damage to granulation tissue during wound healing. Int. J. Tissue React. 24: 65-71.
15. Lee, J. H., J. Y. Jung, and D. Bang. 2007. The efficacy of topical 0.2% hyaluronic acid gel on recurrent oral ulcers: comparison between recurrent aphthous ulcers and the oral ulcers of Behçet's disease. J. Eur. Acad. Dermatol. Venereol. 22: 590-595.
16. Nolan, A., C. Baillie, J. Badminton, M. Rudralingham, and R. A. Seymour. 2006. The efficacy of topical hyaluronic acid in the management of recurrent aphthous ulceration. J. Oral. Pathol. Med. 35: 461-465.
17. Pivarcsi, A., A. Koreck, L. Bodai, M. Szell, C. Szeg, N. Belso, A. Kenderessy-Szabo, Z. Bata-Csorgo, and A. Dobozy. 2004. Differentiation-regulated expression of Toll-like receptors 2 and 4 in HaCaT keratinocytes. Arch. Dermatol. Res. 296: 120-124.
18. Lebre, M. C., A. M. van der Aar, L. van Baarsen, T. M. van Capel, J. H. Schuitemaker, M. L. Kapsenberg, and E. C. de Jong. 2007. Human keratinocytes express functional Toll-like receptor 3, 4, 5 and 9. J. Invest. Dermatol. 127: 331-341.
19. Chadebech, P., D. Goidin, C. Jacquet, J. Viac, D. Schmitt, and M. J. Staquet. 2003. Use of human reconstructed epidermis to analyze the regulation of β-defensin hBD-1, hBD-2, and hBD-3 expression in response to LPS. Cell Biol. Toxicol. 19: 313-324.
20. Kis, K., L. Bodai, H. Polyanka, K. Eder, A. Pivarcsi, E. Duda, G. Soos, Z. Bata-Csorgo, and L. Kemeny. 2006. Budesonide, but not tacrolimus, affects the immune functions of normal human keratinocytes. Int. Immunopharmacol. 6: 358-368.
21. Ballanger, F., I. Tenaud, C. Volteau, A. Khammari, and B. Dréno. 2008. Antiinflammatory effects of lithium gluconate on keratinocytes: a possible explanation for efficiency in seborrhoeic dermatitis. Arch. Dermatol. Res. 300: 215-223.
22. Morrison, G. M., D. J. Davidson, and J. R. Dorin. 1999. A novel mouse β defensin, Defb 2, which is upregulated in the airways by lipopolysaccharide. FEBS Lett. 442: 112-116.
23. Ikeda, A., Y. Nakanishi, T. Sakimoto, J. Shoji, M. Sawa, and N. Nemoto. 2006. Expression of β defensins in ocular surface tissue of experimentally developed allergic conjunctivitis mouse model. Jpn. J. Ophthalmol. 50: 1-6.
24. Harder, J., J. Bartels, E. Christophers, and J. M. Schröder. 1997. A peptide antibiotic from human skin. Nature 387: 861.
25. Kim, D. C., S. H. Kim, M. W. Jeong, N. I. Baek, and K. I. Kim. 2005. Effect of rottlerin, a PKC δ inhibitor, on TLR-4 dependent activation of murine microglia. Biochem. Biophys. Res. Commun. 337: 110-115.
26. Aksoy, E., M. Goldman, and F. Willems. 2004. Proteine kinase C ε: a new target to control inflammation and immune-mediated disorders. Int. J. Biochem. Cell Biol. 36: 183-188.
27. Raghav, S. K., B. Gupta, A. Shrivastava, and H. R. Das. 2007. Inhibition of lipopolysaccharide-inducible nitric oxide synthase and IL-1β through suppression of NF-κB activation by 3-(1′-1′-dimethyl-allyl)-6- hydroxy-7-methoxy-coumarin isolated from Ruta graveolens L. Eur. J. Pharmacol. 560: 69-80.
28. Lu, Z., K. Kim, M. A. Suico, T. Shuto, J. Li, and H. Kai. 2004. MEF up-regulates human β-defensin 2 expression in epithelial cells. FEBS Lett. 561: 117-121.
29. Jiang, D., J. Liang, and P. W. Noble. 2007. Hyaluronan in tissue and repair. Annu. Rev. Cell. Dev. Biol. 23: 435-461.
30. Schmid, P., O. Grenet, J. Medina, S. D. Chibout, C. Osborne, and D. A. Cox. 2001. An intrinsic antibiotic mechanism in wounds and tissue engineered skin. J. Invest. Dermatol. 116: 471-472.
31. Butmarc, J., T. Yufit, P. Carson, and V. Falanga. 2004. Human β-defensin-2 expression is increased in chronic wounds. Wound Repair Regen. 12: 439-443.
32. Sørensen, O. E., J. B. Cowland, K. Theilgaard-Mönch, L. Liu, T. Ganz, and N. Borregaard. 2003. Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J. Immunol. 170: 5583-5589.
33. Sørensen, O. E., D. R. Thapa, K. M. Roupé, E. V. Valore, U. Sjöbring, A. A. Roberts, A. Schmidtchen, and T. Ganz. 2006. Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor. J. Clin. Invest. 116: 1878-1885.
34. Namjoshi, S., R. Caccetta, and H. A. Benson. 2007. Skin peptides: biological activity and therapeutic opportunities. J. Pharm. Sci. 97: 2524-2542.
35. Goodarzi, H., J. Trowbridge, and R. L. Gallo. 2007 Innate immunity: a cutaneous perspective. Clin. Rev. Allergy Immunol. 33: 15-26.
36. Matzinger, P. 2004. The danger model: a renewed sense of self. Science 296: 301-305.
37. Hajishengallis, G., H. Sojar, R. J. Genco, and E. DeNardin. 2004. Intracellular signaling and cytokine induction upon interactions of Porphyromonas gingivalis fimbriae with pattern-recognition receptors. Immunol. Invest. 33: 157-172.
38. Uehara, A., Y. Fujimoto, K. Fukase, and H. Takada. 2007. Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. Mol. Immunol. 44: 3100-3111.
39. Krisanaprakornkit, S., J. R. Kimball, A. Weinberg, R. P. Darveau, B. W. Bainbridge, and B. A. Dale. 2000. Inducible expression of human β-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect. Immun. 68: 2907-2915.
40. Harder, J., U. Meyer-Hoffert, L. M. Teran, L. Schwichtenberg, J. Bartels, S. Maune, and J. M. Schroder. 2000. Mucoid Pseudomonas aeruginosa, TNF-α, and IL-1β, but not IL-6, induce human β-defensin-2 in respiratory epithelia. Am. J. Respir. Cell Mol. Biol. 22: 714-721.
41. Liu, L., L. Wang, H. P. Jia, C. Zhao, H. H. Heng, B. C. Schutte, P. B. McCray, Jr., and Ganz, T. 1998. Structure and mapping of the human β-defensin HBD-2 gene and its expression at sites of inflammation. Gene 222: 237-244.